Articles citing this paper
The impact on health outcome measures of switching to generic medicines consequent to reference pricing: the case of olanzapine in New Zealand
Charon Lessing, Toni Ashton and Peter Davis
7(2) pp.94 - 101
9 articles found in Crossref database.
Impact of the introduction of mandatory generic substitution in South Africa: private sector sales of generic and originator medicines for chronic diseases
Gray Andrew Lofts,
Santa‐Ana‐Tellez Yared, J Wirtz Veronika
Tropical Medicine & International Health. 2016 21(12). p.1504
Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications
Fadare Joseph O.,
Oshikoya Kazeem A.,
Ogunleye Olayinka O.,
Desalu Olufemi O.,
Ferrario Alessandra,
Enwere Okezie O.,
Adeoti Adekunle,
Sunmonu Taofiki A.,
Massele Amos,
Baker Amanj, Godman Brian
Hospital Practice. 2018 46(2). p.77
Switching medication products during the treatment of psychiatric illness
Blier Pierre,
Margolese Howard C.,
Wilson E Adriana, Boucher Matthieu
International Journal of Psychiatry in Clinical Practice. 2019 23(1). p.2
The impact of the reference pricing policy in China on drug procurement and cost
Jiang Bin,
Zhou Ruo Jing, Feng Xing Lin
Health Policy and Planning. 2022 37(1). p.73
Generic switching: Do future physicians in Jordan have enough knowledge and a positive attitude?
Al Zoubi Sura,
Gharaibeh Lobna,
Al-Masri Batool,
Alsahele Ahmad B., AL-Masaeid Buthainah
Frontiers in Pharmacology. 2022 13
Patient factors associated with oral generic olanzapine initiation and substitution among Medicaid beneficiaries: a new user cohort study
Mishuk Ahmed Ullah,
Chen Li,
Li Chao,
Huo Nan,
Hansen Richard A.,
Harris Ilene,
Kiptanui Zippora, Qian Jingjing
Current Medical Research and Opinion. 2021 37(4). p.655
Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future
Mahmood Sidra,
Hussain Shahzad,
ur Rehman Taufeeq,
Barbui Corrado,
Kurdi Amanj Baker, Godman Brian
Current Medical Research and Opinion. 2019 35(1). p.51
Comparison of the effectiveness of brand-name and generic antipsychotic drugs for treating patients with schizophrenia in Taiwan
Hsu Chih-Wei,
Lee Sheng-Yu, Wang Liang-Jen
Schizophrenia Research. 2018 193 p.107
Does China’s competitive generic substitution policy deliver equivalent clinical outcomes? A pilot study with two generic formulations of olanzepine
Zhang Chao,
Ding Yudan,
Wu Zhenzhen,
Wang Juan,
Wu Xiangping, Xie Weiwei
Frontiers in Pharmacology. 2023 14
